Public Health On Call

About this episode:  
Vitamin A is essential for good vision, a healthy immune system, cell growth, and reproductive health, and it has proved to be a critical tool in fighting childhood mortality in parts of the world where access to nutrient-rich foods is limited. But while Vitamin A has saved many lives, supplementation isn't necessary for most people, despite what you may read online. In this episode: a slate of experts from the Johns Hopkins University join host Lindsay Smith Rogers to dive into the history of vitamin A supplementation, how it has shaped global health, and what this incredible nutrient can't do despite its benefits.  
 
Note: This episode was produced in collaboration with the Johns Hopkins University sesquicentennial campaign.
Guests: 
Brian Foster, PhD, MSc, is an associate professor of medicine at the Johns Hopkins School of Medicine and director of the laboratory of cardiovascular biochemistry. 
Amanda Palmer, PhD, MHS, is an associate professor of International Health at the Johns Hopkins Bloomberg School of Public Health. 
Dr. Alfred Sommer, MHS, is a Johns Hopkins University distinguished service professor and dean emeritus of the Johns Hopkins Bloomberg School of Public Health. 
Keith P. West, Jr., DrPH, MPH, is the George G. Graham professor of International Health at the Johns Hopkins Bloomberg School of Public Health. 
Host: 
Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. 
Show links and related content: 
The Story of Dean Sommer and Vitamin A—Johns Hopkins Bloomberg School of Public Health 

Bellagio brief: vitamin A deficiency and childhood mortality—Bulletin of the Pan American Health Organization 

Moving from science to public health programs: lessons from vitamin—American Journal of Clinical Nutrition 

Double blind, cluster randomised trial of low dose supplementation with vitamin A or β carotene on mortality related to pregnancy in Nepal—The BMJ 

Posner Fellow Studies Role of Vitamin A and Advocates for Patients—Johns Hopkins University & Medicine 

In A Grain Of Golden Rice, A World Of Controversy Over GMO Foods—NPR 

Poison Centers Observe Increased Vitamin A Exposures in Children During Measles Outbreak—America's Poison Centers 

Remedy Supported by Kennedy Leaves Some Measles Patients More Ill—New York Times

Transcript information:
Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. You can also email PublicHealthQuestion@jhu.edu to request a transcript.
AI disclosure (as of September 2026):
The conversations you hear on the podcast are happening between real humans, and real humans are developing and researching episodes behind the scenes. In addition to real human audio engineers, Public Health On Call uses AI production tools to assist with the removal of filler words and improve audio quality. If you have any questions about our use of AI, please reach out to PublicHealthQuestion@jhu.edu. 
Contact us:
Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. You can also leave us a voicemail at ‪(667) 217-6214‬ for the chance to hear your voice on the podcast.
Follow us:
@‌PublicHealthPod on Bluesky

@‌PublicHealthPod on Instagram

@‌JohnsHopkinsSPH on Facebook

@‌PublicHealthOnCall on YouTube

Here's our RSS feed

Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode:  
Scientists, tech companies, and world leaders are sounding the alarm on potential threats to humanity as AI models grow more powerful. Is part of this threat related to the technology's biological capabilities? In this episode: Tom Inglesby, director of the Johns Hopkins Center for Health Security, answers: yes. He provides an overview of what AI is capable of doing and what possible threats could be around the corner if policies don't intervene to control these developments.
Guest: 
Dr. Tom Inglesby is a professor of Environmental Health and Engineering and the director of the Johns Hopkins Center for Health Security.
Host: 
Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. 
Show links and related content: 
A.I. Queries From Abroad Raise Fears of a Biological Weapons Race—The New York Times

How AI makes biological research more dangerous—Axios

Detecting and countering misuse of AI: September 2026—Anthropic

Generative design of bacteriophages with genome language models—Science

Transcript information:
Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. You can also email PublicHealthQuestion@jhu.edu to request a transcript.
AI disclosure (as of September 2026):
The conversations you hear on the podcast are happening between real humans, and real humans are developing and researching episodes behind the scenes. In addition to real human audio engineers, Public Health On Call uses AI production tools to assist with the removal of filler words and improve audio quality. If you have any questions about our use of AI, please reach out to PublicHealthQuestion@jhu.edu. 
Contact us:
Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. You can also leave us a voicemail at ‪(667) 217-6214‬ for the chance to hear your voice on the podcast.
Follow us:
@‌PublicHealthPod on Bluesky

@‌PublicHealthPod on Instagram

@‌JohnsHopkinsSPH on Facebook

@‌PublicHealthOnCall on YouTube

Here's our RSS feed

Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode:  
For the first time ever, mRNA flu shots are available this respiratory virus season for adults age 50 and older, offering an opportunity to create vaccines better tailored to certain strains of the virus. Moderna's mFLUSIVA was approved by the FDA this summer and is available in some pharmacies. In this episode: Vaccine expert Anna Durbin explains how the vaccine works, discusses the current data on its safety and efficacy, and reflects on the quest for a universal flu vaccine.
Guest: 
Dr. Anna Durbin is a professor of International Health and the director of the Johns Hopkins Center for Immunization Research. 
Host: 
Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs.
Show links and related content: 
New mRNA Flu Vaccine Makes This Flu Season 'One to Watch'—Johns Hopkins Bloomberg School of Public Health

August 5, 2026 Clinical Review - MFLUSIVA—FDA

How Influenza (Flu) Vaccines Are Made—CDC

How Flu Viruses Can Change: "Drift" and "Shift"—CDC

The Long History of mRNA Vaccines—Johns Hopkins Bloomberg School of Public Health

A Guide to Fall Vaccines for People Who Are Immunocompromised and Those Who Care For Them—Public Health On Call (September 2026)

Transcript information:
Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. You can also email PublicHealthQuestion@jhu.edu to request a transcript.
AI disclosure (as of September 2026):
The conversations you hear on the podcast are happening between real humans, and real humans are developing and researching episodes behind the scenes. In addition to real human audio engineers, Public Health On Call uses AI production tools to assist with the removal of filler words and improve audio quality. If you have any questions about our use of AI, please reach out to PublicHealthQuestion@jhu.edu. 
Contact us:
Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.
Follow us:
@‌PublicHealthPod on Bluesky

@‌PublicHealthPod on Instagram

@‌JohnsHopkinsSPH on Facebook

@‌PublicHealthOnCall on YouTube

Here's our RSS feed

Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode:  
Life expectancies for those living with HIV are nearly identical to those living without the virus, thanks to groundbreaking advancements in medicine and care. But that data point doesn't tell the full story about the unique needs and nuanced challenges facing those with HIV, particularly as that population skews increasingly older. In this episode: Keri Althoff and Vanessa Johnson, co-authors of a new report on aging and HIV, explain why and how prevention and treatment should adapt to support lifelong health.
Guest: 
Keri N. Althoff, PhD, MPH, is a professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health.
Vanessa Johnson, MPA, JD, is a recognized advocate, community leader, and champion for people living with HIV. She is the co-executive director at Ribbon, a social justice organization, and senior advisor to ROC4Aging+, a project that seeks to improve quality of life for those aging with HIV.
Host: 
Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs.
Show links and related content: 
The Lancet HIV Commission on ageing and HIV: a global perspective—The Lancet HIV Commissions

Amy Justice and Keri Althoff on the Lancet HIV Commission on ageing and HIV—The Lancet

On the Cusp of Eliminating HIV—Hopkins Bloomberg Public Health Magazine

Growing and Aging: The Population of People Living with HIV—Johns Hopkins Bloomberg School of Public Health

"On Going Backwards": A New HIV/AIDS Epidemic?—Public Health On Call (May 2024)

Transcript information:
Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. You can also email PublicHealthQuestion@jhu.edu to request a transcript.
AI disclosure (as of September 2026):
The conversations you hear on the podcast are happening between real humans, and real humans are developing and researching episodes behind the scenes. In addition to real human audio engineers, Public Health On Call uses AI production tools to assist with the removal of filler words and improve audio quality. If you have any questions about our use of AI, please reach out to PublicHealthQuestion@jhu.edu. 
Contact us:
Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.
Follow us:
@‌PublicHealthPod on Bluesky

@‌PublicHealthPod on Instagram

@‌JohnsHopkinsSPH on Facebook

@‌PublicHealthOnCall on YouTube

Here's our RSS feed

Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode:  
September is Sickle Cell Awareness Month, recognizing a severe disease that affects an estimated 100,000 people in the U.S. In this episode: Shayla Ellington, who lives with Hemoglobin SC disease, shares how her diagnosis has shaped her life, how she sees the underfunding of research and treatment, and how she uses her public health and business school training to advocate for a brighter future.
Guest: 
Shayla Ellington, MPH, MBA, is a recent alumna of the Johns Hopkins Bloomberg School of Public Health and Carey Business School.
Host: 
Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. 
Show links and related content: 
About Sickle Cell Disease—Sickle Cell Disease Association of America

Beyond Gene Therapies: People With Sickle Cell Disease Need Comprehensive Care—Health Affairs

Sickle Cell Disease: Genetic Therapies and Treatment Hurdles—Public Health On Call (August 2025)

Transcript information:
Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. You can also email PublicHealthQuestion@jhu.edu to request a transcript.
AI disclosure (as of September 2026):
The conversations you hear on the podcast are happening between real humans, and real humans are developing and researching episodes behind the scenes. In addition to real human audio engineers, Public Health On Call uses AI production tools to assist with the removal of filler words and improve audio quality. If you have any questions about our use of AI, please reach out to PublicHealthQuestion@jhu.edu. 
Contact us:
Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.
Follow us:
@‌PublicHealthPod on Bluesky

@‌PublicHealthPod on Instagram

@‌JohnsHopkinsSPH on Facebook

@‌PublicHealthOnCall on YouTube

Here's our RSS feed

Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.